Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Defense was posted on May 6, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

BUTORPHANOL TARTRAT

Closed
SPE2DP-26-T-3283Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412
New
Federal
6505--Dutasteride CapsulesThe Department of Veterans Affairs National Acquisition Center plans to issue a Request for Proposal (RFP 36E79726R0029) for the procurement of Dutasteride Capsules to serve multiple federal agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This unrestricted contract aims to secure a reliable supply source for Dutasteride 0.5MG capsules in both 30-count and 90-count bottles, with annual estimated usage of approximately 3,912 and 25,502 bottles respectively. The contract will be awarded to a single responsible offeror who can provide an uninterrupted supply and will have a one-year base period followed by four one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must supply the drug under the exact name on the label, with a unique National Drug Code (NDC) exclusive to the offeror. The contractor’s label must be the sole label on the product, with VA labels designed to adhere securely on top without obscuring important information such as barcodes, expiration dates, and lot numbers. Packaging requirements include safety caps that meet specific design criteria with a minimum bottle volume of 120cc and cylindrical shape to accommodate appropriate labeling sizes. The solicitation will be released in a commercial item format in accordance with FAR Part 12 around June 22, 2026, with proposals due by July 7, 2026. Interested parties should monitor SAM.gov for updates and submit offers electronically; efforts to obtain paper copies will not be accommodated. The contract specialist and primary point of contact for this procurement is Richard Mahario.
Nac Pharmaceuticals (36E797)

POSTED

1 day ago

DEADLINE

in 21 days

AI Contract Overview

Show more

This contract covers the procurement of Butorphanol Tartrate Injection, a veterinary drug used for pain relief associated with colic in adult horses and yearlings. The medication is provided in a 10 mg/mL concentration, packaged in a 50 mL vial, and classified as a DEA Schedule IV controlled substance. It requires storage at controlled room temperature (20-25°C or 68-77°F) and must be secured according to its controlled substance status. The contract mandates compliance with medical marking standards and packaging requirements as per Defense Logistics Agency (DLA) specifications. The product has a non-extendable shelf life of 24 months and is regulated by the FDA. The contract is designated under solicitation number SPE2DP-26-T-3283 and involves a purchase of one vial with a delivery deadline of 20 days to a destination within APO 96368-5268. Inspection and acceptance will occur upon delivery. Multiple manufacturers and suppliers, including Merck, Zoetis, Covetrus North America, and Patterson Veterinary Supply, are noted as sources for the product. The contract emphasizes adherence to technical and quality requirements listed in the DLA Master List and requires contracting officials to coordinate with product specialists for FDA regulation confirmation during the bidding process.

General Info

Procurement of FDA-regulated Butorphanol Injection, 10 mg/mL, one vial, controlled substance, 24-month shelf life.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

UNIT 5268, APO, AP, 96368-5268, US

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-3283.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Office AddressUS
Contacts

Full Description

Show more
BUTORPHANOL TARTRAT
BUTORPHANOL TARTRATE INJECTION, VETERINARY
.
10 MG/ML, 50 ML VIAL; FOR PAIN RELIEF ASSOCIATED WITH
COLIC IN ADULT HORSES AND YEARLINGS;
DEA SCHEDULED DRUG CLASS IV
.
UNIT OF ISSUE: VIAL (VI) OF 50ML.
.
STORE AT CONTROLLED ROOM TEMPERATURE 20-25C (68-77F); SECURED (C-IV)
.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/ .
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. . .. RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
MERCK SHARP & DOHME LLC 6B2S4 P/N 017070 MWI VETERINARY SUPPLY, INC. 1VLG2 P/N NDC67185-0722-66 ZOETIS INC. 0M1P3 P/N 10009984 ZOETIS INC. 0M1P3 P/N NDC54771-2033-20 COVETRUS NORTH AMERICA, LLC 4PG41 P/N 029088 PATTERSON VETERINARY SUPPLY, INC. 3G5T7 P/N 07-803-7090
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-3283
SECTION B
PR: 7016655669 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016655669 0001 VI 1.000
NSN/MATERIAL:6509015310967
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6509-01-531-0967 Quantity: 1 VI Purchase Request: 7016655669QTY: 1 Delivery: 20 days ADO